Metraipolis › archive › dc_0cd9d46d59ef

ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB — Europe PMC PMID:42148076

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42148076
DOI
10.3389/fimmu.2026.1797767
License (as archived)
solo-consultazione
Archived
2026-11-02T20:26:59.103Z
SHA-256 of the archived text
1e3eed90079f5ffe0eb53d832b1dcfa6d93805255b1de786166809145e2fe5ab
Stable URL of this page
https://metraipolis.com/documento/dc_0cd9d46d59ef

How to cite

ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB — Europe PMC PMID:42148076 — Europe PMC (en), https://europepmc.org/article/MED/42148076 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cd9d46d59ef (Metraipolis archive dc_0cd9d46d59ef, sha256 1e3eed90079f5ffe0eb53d832b1dcfa6d93805255b1de786166809145e2fe5ab)
BibTeX
@misc{dc0cd9d46d59ef,
  title = {ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB — Europe PMC PMID:42148076},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148076},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cd9d46d59ef; sha256 1e3eed90079f5ffe0eb53d832b1dcfa6d93805255b1de786166809145e2fe5ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148076. Agents can read the archived copy with the MCP tool read_document.